Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History PRPO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics PRPO

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Precipio Inc

PRPO
Current price
15.70 USD -0.25 USD (-1.60%)
Last closed 15.82 USD
ISIN US74019L5030
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 18 219 720 USD
Yield for 12 month +229.04 %
1Y
3Y
5Y
10Y
15Y
PRPO
21.11.2021 - 28.11.2021

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut. Address: 4 Science Park, New Haven, CT, United States, 06511

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

19.00 USD

P/E Ratio

Dividend Yield

Financials PRPO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures PRPO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+15 965 000 USD

Last Year

+15 197 000 USD

Current Quarter

+4 257 000 USD

Last Quarter

+5 450 000 USD

Current Year

+7 559 000 USD

Last Year

+6 018 000 USD

Current Quarter

+2 140 000 USD

Last Quarter

+2 646 000 USD
EBITDA -1 667 000 USD
Operating Margin TTM -17.43 %
Price to Earnings
Return On Assets TTM -10.90 %
PEG Ratio
Return On Equity TTM -25.29 %
Wall Street Target Price 19.00 USD
Revenue TTM 20 029 000 USD
Book Value 7.78 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 43.60 %
Dividend Yield
Gross Profit TTM 8 779 000 USD
Earnings per share -2.06 USD
Diluted Eps TTM -2.06 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -15.45 %

Stock Valuation PRPO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 15.43
Enterprise Value Revenue 0.97
Price Sales TTM 0.91
Enterprise Value EBITDA -1.15
Price Book MRQ 1.56

Technical Indicators PRPO

For 52 Weeks

3.90 USD 12.45 USD
50 Day MA 9.22 USD
Shares Short Prior Month 9 378
200 Day MA 7.11 USD
Short Ratio 0.57
Shares Short 5 617
Short Percent 0.41 %